Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Mikael Björnstedt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2831-3837; OpenAlex author ID A5071887651. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 11

  1. Se-methylselenocysteine induces NRF2-ATF4 stress signaling and ferroptosis-associated remodeling in pancreatic cancer. Co-author DOI 10.1016/j.freeradbiomed.2026.08.003↗
  2. Transcriptomic profiling reveals complement activation in chronic pancreatitis adjacent to pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.imbio.2026.153239↗
  3. Selenite modulates phenotype-dependent epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: integrated in vitro analyses and patient-derived … Co-author DOI 10.1186/s13046-026-03778-4↗
  4. An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo. Co-author DOI 10.1016/j.tranon.2025.102512↗
  5. Investigating the Molecular Impact of GGMSC on Redox and Metabolic Pathways in Pancreatic Cancer Cells. Last author DOI 10.3390/antiox14101163↗
  6. Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-guided treatment of pancreatic cancer. Co-author DOI 10.1016/j.esmogo.2024.100070↗
  7. Genderized Gut and Oral Microbiome Shifts: Uncovering Sex-Specific Dysbiosis in Pancreatic Cancer Co-author DOI 10.1101/2024.10.02.616338↗
  8. Exploration of Patient-Derived Pancreatic Ductal Adenocarcinoma Ex Vivo Tissue for Treatment Response. Co-author DOI 10.3390/antiox12010167↗
  9. Drug-induced tumor-specific cytotoxicity in a whole tissue ex vivo model of human pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fonc.2022.965182↗
  10. Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-020-65911-3↗
  11. Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-019-38603-w↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joakim Dillner · 7 shared papers, 2020–2026 · strength 1.90
  2. Mehran Ghaderi · 7 shared papers, 2020–2026 · strength 1.90
  3. Carlos Fernández Moro · 9 shared papers, 2019–2026 · strength 1.84
  4. Arun Kumar Selvam · 6 shared papers, 2022–2026 · strength 1.66
  5. Tímea Szekerczés · 3 shared papers, 2023–2026 · strength 0.72
  6. Matthias J. Löhr · 3 shared papers, 2019–2024 · strength 0.49
  7. Béla Bozóky · 2 shared papers, 2022–2025 · strength 0.36
  8. Ozan Aricak · 1 shared paper, 2026 · strength 0.32
  9. Caroline Sophie Verbeke · 2 shared papers, 2019–2020 · strength 0.23
  10. Zara Ahmed Khan · 1 shared paper, 2024 · strength 0.21
  11. Rainer Lothar Heuchel · 1 shared paper, 2024 · strength 0.21
  12. Margaret Chen · 1 shared paper, 2024 · strength 0.21
  13. Dhifaf Sarhan · 1 shared paper, 2024 · strength 0.21
  14. Johan Nilvebrant · 1 shared paper, 2025 · strength 0.20
  15. Per‐Åke Nygren · 1 shared paper, 2025 · strength 0.20
  16. Marco Del Chiaro · 1 shared paper, 2024 · strength 0.18
  17. Linnéa Malgerud · 1 shared paper, 2024 · strength 0.18
  18. Maximilian Kordes · 1 shared paper, 2024 · strength 0.18
  19. Raffaella Pozzi Mucelli · 1 shared paper, 2024 · strength 0.18
  20. Jan‐Erik Frödin · 1 shared paper, 2024 · strength 0.18
  21. Poya Ghorbani · 1 shared paper, 2024 · strength 0.18
  22. Maria Gustafsson Liljefors · 1 shared paper, 2024 · strength 0.18
  23. Nikolaos Kartalis · 1 shared paper, 2024 · strength 0.18
  24. Marco Gerling · 1 shared paper, 2022 · strength 0.16
  25. Sougat Misra · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.